Open AccessCognitive impairment in patients with diabetes mellitus in the conditions of COVID-19
Author(s) -
Nadiia Zherdova
Publication year - 2021
Publication title -
meždunarodnyj nevrologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2307-1419
pISSN - 2224-0713
DOI - 10.22141/2224-0713.17.5.2021.238525
Subject(s) - medicine , cognition , diabetes mellitus , covid-19 , disease , cognitive impairment , type 2 diabetes mellitus , pathogenesis , intensive care medicine , psychiatry , endocrinology , pathology , infectious disease (medical specialty) , outbreak
This review highlights the state of cognitive functions in patients with metabolic syndrome, diabetes mellitus at the stage of detection of the underlying disease and after COVID-19. The main links in the pathogenesis of cognitive dysfunction in patients with diabetes are explained, and based on previous studies of SARS-CoV-1 and MERS-CoV, possible mechanisms of cognitive impairment in patients infected with COVID-19 are revealed. Methods for the correction of cognitive disorders with the use of modern nootropics, such as phenibut, are proposed.